Skip to main content

Day: May 19, 2021

BJ’s Restaurants, Inc. Announces Virtual Format for 2021 Annual Meeting of Shareholders

HUNTINGTON BEACH, Calif., May 19, 2021 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) announced today that it has elected to offer a virtual meeting format, via webcast, for its 2021 Annual Meeting of Shareholders (the “Annual Meeting”) due to continuing concerns related to the COVID-19 pandemic.    The Annual Meeting date and time have not been changed and will take place on Wednesday, June 9, 2021 at 9:00 a.m. Pacific Daylight Time. However, in light of health and safety concerns, as well as restrictions under California state and applicable local laws pertaining to the COVID-19 pandemic, the Company will not be able to allow shareholders to physically attend the meeting and attendance will be limited to selected members of its executive team, Gerald (“Jerry”) Deitchle, Chairman of the Board, and, possibly some of the...

Continue reading

AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics

Seattle, May 19, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for Best Acquisition, Cross-Border into Italy, presented by KPMG, Fineurop Soditic, and others. This award is dedicated to showcasing the best of the Italian M&A market. “We are incredibly honored to have received this award,” says AGC Biologics Chief Executive Officer, Patricio Massera. “A tremendous amount of care and skill went into this acquisition from both of the teams at AGC and the former MolMed, and we’re thrilled to be working together as one – continually innovating to meet the growing needs of our customers and their patients.” The Award Jury, which met in early 2021, ranked the AGC—MolMed acquisition first in the Foreign...

Continue reading

DSM: Transaction in Own Shares

Downing Strategic Micro-Cap Investment Trust Plc (the “Company”)LEI: 213800QMYPUW4POFFX69Transaction in Own Shares19 May 2021 The Company announces that on 19 May 2021 it bought back 28,860 Ordinary Shares of £0.001 each in the capital of the Company, at a price of 75.75 pence per share. These shares will be held in treasury. Following settlement of this purchase the number of Ordinary shares in issue, Ordinary shares held in treasury (which do not carry any voting rights) and total voting rights will be:Ordinary Shares in issue (including treasury shares) 55,550,002Ordinary Shares held in treasury         3,600,661TOTAL VOTING RIGHTS attached to Ordinary Shares in issue (excluding treasury shares)51,949,341For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should...

Continue reading

Freddie Mac Prices $938 Million Multifamily K-Deal, K-F112

MCLEAN, Va., May 19, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) has priced a new offering of Structured Pass-Through Certificates (K Certificates), which includes a class of floating rate bonds indexed to the Secured Overnight Financing Rate (SOFR). The approximately $938 million in K Certificates (K-F112 Certificates) are expected to settle on or about May 27, 2021. The K-F112 Certificates are backed by floating-rate multifamily mortgages with 10-year terms, which are SOFR-based. K-F112 PricingClass Principal/NotionalAmount (mm) WeightedAverageLife(Years) DiscountMargin Coupon Dollar PriceAS $938.999 9.57 23 30-day SOFR avg + 23 100.000XS Non-OfferedDetailsCo-Lead Managers and Joint Bookrunners: Wells Fargo Securities, LLC and Citigroup Global Markets Inc. Co-Managers: CastleOak Securities, L.P., NatAlliance...

Continue reading

Golden Leaf Holdings Announces Closing of Transformational Acquisition of Retail Store Chain in Oregon

PORTLAND, Ore., May 19, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf,” “GLH” or the “Company”), operating as Chalice Brands, a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale and distribution, announces the signing of a definitive agreement today, May 19, and concurrent closing of the purchase of 100% ownership in SMS Ventures, LLC, dba Homegrown Oregon (“Homegrown”), a chain of five retail dispensaries located in Portland, Salem and Albany, Oregon, for total consideration of approximately US$9.75 million or 0.9 times Homegrown’s first quarter 2021 annualized revenue2. The added fact that Homegrown is profitable makes this a highly accretive acquisition for Golden Leaf earnings per share. Transaction Highlights:Total consideration of...

Continue reading

Nexity: Main terms and conditions of the share buy-back programme in accordance with the conditions and obligations set by Articles 241-1 to 241-7 of the General Regulations of the Autorité des marchés financiers (AMF)

NEXITY Société anonyme with a share capital of €280,648,620 Registered office: 19, rue de Vienne – TSA 50029 – 75801 PARIS Cedex 08 444 346 795 RCS Paris   Main terms and conditions of the share buy-back programme in accordance with the conditions and obligations set by Articles 241-1 to 241-7 of the General Regulations of the Autorité des marchés financiers (AMF)   Implementation of the share buy-back programme authorised by the Combined Shareholders’ meeting on May 19, 2021   Issuer: Nexity / ISIN code FR 0010112524 (compartment A) Stock concerned: Ordinary shares Implementation authorized by: Combined Shareholders’ meeting on May 19, 2021 Implementation decision date: May 19, 2021 Maximum proportion of the share capital that may be acquired pursuant to the Shareholders’ authorization: 10% of the number of ordinary shares composing...

Continue reading

Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results

Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN DUBLIN, Ireland, May 19, 2021 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2021 on Tuesday, May 25, 2021. The Company has scheduled a conference call for that same day, Tuesday May 25, 2021 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.Interested parties can access the call by dialing:  US Toll Free:  1-844-861-5499  International Toll: 1-412-317-6581  Ireland Toll: 014311269  Ireland Toll Free: 1800932830Please ask to be joined into the Trinity Biotech call.A simultaneous webcast of the call can be accessed at:https://services.choruscall.com/mediaframe/webcast.html?webcastid=VZlwzsvYA...

Continue reading

Quantum Genomics Announces the Publication of New Scientific Article in Biomedicine & Pharmacotherapy Which Further Strengthens its Phase III Development Plan in Difficult to Treat and Resistant Hypertension

PARIS, May 19, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat difficult to treat/resistant hypertension and heart failure, announces the publication in Biomedicine & Pharmacotherapy of a new peer-reviewed scientific article reporting the efficacy of firibastat in combination with enalapril and hydrochlorothiazide in an experimental model of salt-sensitive hypertension (the DOCA-salt hypertensive rat). The article, entitled “Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats” is available online on the website of the journal Biomedicine & Pharmacotherapy...

Continue reading

Voltalia’s Shareholders’ meeting of May 19, 2021 approves all the resolutions submitted to the vote

Renewal of the terms of office of Board members Laurence Mulliez and the companies The Green Option and Creadev for a period of three years Renewal of the terms of office of Board Member André-Paul Leclercq for a period of one year Departure of independent Board member Evelyne Tall  Adoption of the status of Mission Company in Voltalia’s articles of association, within the meaning of the French PACTE1 law: Voltalia is the first company in its sector and now the third listed company to adopt this statusVoltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, held its Shareholders’ meeting today and publishes the minutes of the event. In the context of the Covid-19 pandemic, the Shareholders’ meeting was held in Paris in camera without the physical presence of the shareholders and all the...

Continue reading

AMD Announces $4 Billion Share Repurchase Program

SANTA CLARA, Calif., May 19, 2021 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced that its Board of Directors approved a new share repurchase program. Under this program, the company intends to repurchase up to $4 billion of outstanding AMD common stock. AMD expects to fund repurchases through cash generated from operations which have been strengthened by the company’s strong operational results. “Today’s announcement reflects our confidence in AMD’s business and the successful execution of our multi-year growth strategy,” said Dr. Lisa Su, AMD president and CEO. “Our strong financial results and growing cash generation enable us to invest in the business and begin returning capital to our shareholders.” Under this program, which is designed to return value to AMD stockholders, offset dilution from stock issuances, and reduce...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.